ABBV
AbbVie Inc.Company Information
- Company Name
- AbbVie Inc.
- CIK
- CIK0001551152
- Category
- Large accelerated filer
- Ticker: Exchange
- ABBV: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ABBV
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-03-04
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 178,420.17
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 1,195,264,665
- Shares outstanding
- 1,770,000,000
- Ownership
- 67.53%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- 4.24%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 6,569 | 9,391 | 5,229 | 5,629 | 6,467 | 5,175 | 5,524 | 7,257 | 13,130 | 18,067 | 12,814 | 13,287 | ||||||
| Short Term Investments | - | - | 28 | 42 | 0 | 1 | 31 | 28 | 27 | 2 | 2 | 3 | ||||||
| Accounts Receivable Net Current | 13,824 | 12,479 | 12,589 | 12,769 | 12,637 | 12,477 | 10,919 | 11,472 | 11,724 | 11,949 | 11,155 | 11,412 | ||||||
| Inventory Net | 5,127 | 5,049 | 4,951 | 4,938 | 4,960 | 4,526 | 4,181 | 4,450 | 4,218 | 4,245 | 4,099 | 3,981 | ||||||
| Prepaid Expense And Other Assets Current | 8,149 | 6,610 | 6,265 | 5,161 | 5,197 | 5,496 | 4,927 | 4,578 | 4,717 | 4,608 | 4,932 | 4,541 | ||||||
| Assets Current | 33,669 | 33,529 | 29,062 | 28,539 | 29,261 | 27,675 | 25,582 | 27,785 | 33,816 | 38,871 | 33,002 | 33,224 | ||||||
| Long Term Investments | 266 | 268 | 268 | 291 | 310 | 287 | 279 | 267 | 272 | 305 | 304 | 275 | ||||||
| Property Plant And Equipment Net | 5,796 | 5,687 | 5,628 | 5,483 | 5,283 | 5,237 | 5,134 | 5,141 | 5,023 | 4,980 | 4,989 | 4,934 | ||||||
| Intangible Assets Net Excluding Goodwill | 49,139 | 50,873 | 52,641 | 54,315 | 57,031 | 58,489 | 60,068 | 66,646 | 60,243 | 62,225 | 55,610 | 58,603 | ||||||
| Goodwill | 35,519 | 35,570 | 35,640 | 35,626 | 35,638 | 35,285 | 34,956 | 35,295 | 33,386 | 33,426 | 32,293 | 32,091 | ||||||
| Other Assets Noncurrent | 10,726 | 10,536 | 10,721 | 9,644 | 9,659 | 9,192 | 9,142 | 8,288 | 9,197 | 9,067 | 8,513 | 7,094 | ||||||
| Assets | 135,115 | 136,463 | 133,960 | 133,898 | 137,182 | 136,165 | 135,161 | 143,422 | 141,937 | 148,874 | 134,711 | 136,221 | ||||||
Liabilities Current | ||||||||||||||||||
| Short Term Borrowings | 0 | 0 | 2,499 | 3,790 | 5,556 | 1,593 | 0 | - | - | 3 | 0 | 2 | ||||||
| Long Term Debt And Capital Lease Obligations Current | 8,341 | 8,326 | 6,056 | 1,982 | 1,966 | 3,769 | 6,804 | 12,570 | 12,586 | 10,193 | 7,191 | 5,113 | ||||||
| Accounts Payable And Accrued Liabilities Current | 33,301 | 33,774 | 34,734 | 33,619 | 32,245 | 31,041 | 31,945 | 30,492 | 29,329 | 31,326 | 30,650 | 29,658 | ||||||
| Liabilities Current | 41,642 | 42,100 | 43,289 | 39,391 | 39,767 | 36,403 | 38,749 | 43,062 | 41,915 | 41,522 | 37,841 | 34,773 | ||||||
| Long Term Debt And Capital Lease Obligations | 62,481 | 64,532 | 58,941 | 62,971 | 62,959 | 64,527 | 60,340 | 58,509 | 58,048 | 63,805 | 52,194 | 55,631 | ||||||
| Deferred Income Tax Liabilities Net | 2,277 | 2,332 | 2,389 | 2,480 | 2,554 | 2,582 | 2,579 | 2,749 | 2,726 | 2,722 | 1,952 | 2,044 | ||||||
| Other Liabilities Noncurrent | 34,603 | 34,111 | 32,569 | 31,655 | 32,040 | 31,191 | 30,129 | 33,031 | 32,427 | 32,778 | 32,327 | 31,644 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value Outstanding | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | ||||||
| Treasury Stock Value | -10,618 | -10,611 | -9,146 | -9,143 | -9,147 | -9,137 | -8,201 | -7,848 | -7,838 | -7,829 | -6,533 | -6,525 | ||||||
| Additional Paid In Capital Common Stock | 23,156 | 22,962 | 22,495 | 22,291 | 21,987 | 21,808 | 21,333 | 21,160 | 20,879 | 20,656 | 20,180 | 20,021 | ||||||
| Retained Earnings Accumulated Deficit | -17,333 | -17,872 | -15,493 | -14,234 | -11,503 | -9,527 | -7,900 | -4,964 | -3,768 | -2,384 | -1,000 | 933 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1,158 | -1,153 | -1,144 | -1,574 | -1,538 | -1,742 | -1,925 | -2,334 | -2,513 | -2,454 | -2,305 | -2,353 | ||||||
| Stockholders Equity | -5,888 | -6,612 | -3,270 | -2,599 | -183 | 1,420 | 3,325 | 6,032 | 6,821 | 8,047 | 10,397 | 12,129 | ||||||
| Minority Interest | 47 | 44 | 42 | 43 | 45 | 42 | 39 | 39 | 43 | 40 | 37 | 35 | ||||||
| Liabilities And Stockholders Equity | 135,115 | 136,463 | 133,960 | 133,898 | 137,182 | 136,165 | 135,161 | 143,422 | 141,937 | 148,874 | 134,711 | 136,221 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | ||||||
| Common Stock Shares Issued | 1,844 | 1,844 | 1,839 | 1,838 | 1,837 | 1,837 | 1,832 | 1,831 | 1,830 | 1,830 | 1,823 | 1,823 | ||||||
| Treasury Stock Common Shares | 77 | 77 | 71 | 71 | 71 | 71 | 66 | 64 | 64 | 64 | 57 | 57 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAbbVie Inc. (ABBV) — SEC Financial Statements & Analysis
AbbVie Inc. (ABBV) is a pharmaceutical preparations company, incorporated in DE. AbbVie Inc. trades on NYSE as: ABBV. AbbVie Inc. (ABBV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, AbbVie Inc. carries a market cap of $442.01B, a P/E ratio of 70.04x, a P/B ratio of -75.07x, a P/S ratio of 6.86x, an enterprise value of $506.26B, and an EV/EBITDA multiple of 28.69x. On profitability, it posts a gross margin of 71.48%, an operating margin of 26.20%, a net margin of 9.80%, a Return on Equity (ROE) of -207.91%, a Return on Assets (ROA) of 4.64%, and a Return on Invested Capital (ROIC) of 19.65%. Per share, it reports EPS of $3.57, diluted EPS of $3.56, free cash flow per share of $10.29, and a dividend per share of $6.77. Over the trailing year, it posted revenue growth of 10.39% year-over-year, net income growth of 67.22% year-over-year, and EPS growth of 67.13% year-over-year. On the balance sheet, it maintains a current ratio of 0.81x, a quick ratio of 0.49x, working capital of $-7.97B, a debt-to-equity ratio of -7.07x, a debt ratio of 0.31, an interest coverage ratio of 6.38x, free cash flow of $18.21B (TTM), and net debt of $64.25B. Figures sourced from SEC EDGAR.
- Market Cap
- $442.01B
- P/E TTM
- 70.04x
- EPS TTM
- $3.57
- P/B TTM
- -75.07x
- ROE TTM
- -207.91%
- ROA TTM
- 4.64%
- Debt To Equity
- -7.07x
- Free Cash Flow TTM
- $18.21B
- Net Revenue TTM Growth 1Y
- 10.39%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AbbVie Inc. in?
AbbVie Inc. (ABBV) operates in the Pharmaceutical Preparations industry.
What exchange does ABBV trade on?
AbbVie Inc. (ABBV) trades on the NYSE.
Where is AbbVie Inc. incorporated?
AbbVie Inc. is incorporated in DE.
When was AbbVie Inc. (ABBV)'s most recent SEC filing?
AbbVie Inc. (ABBV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is ABBV's market cap?
AbbVie Inc. (ABBV) has a market capitalization of $442.01B as of 2026-06-30.
What is ABBV's P/E ratio?
AbbVie Inc. (ABBV)'s trailing twelve month P/E ratio is 70.04x as of 2026-06-30.
What is ABBV's EPS (earnings per share)?
AbbVie Inc. (ABBV)'s trailing twelve month EPS is $3.57 as of 2026-06-30.
What is ABBV's ROE (return on equity)?
AbbVie Inc. (ABBV)'s trailing twelve month Return on Equity (ROE) is -207.91% as of 2026-06-30.
What is ABBV's ROA (return on assets)?
AbbVie Inc. (ABBV)'s trailing twelve month Return on Assets (ROA) is 4.64% as of 2026-06-30.
What is ABBV's ROIC (return on invested capital)?
AbbVie Inc. (ABBV)'s trailing twelve month Return on Invested Capital (ROIC) is 19.65% as of 2026-06-30.
What is ABBV's EV/EBITDA?
AbbVie Inc. (ABBV)'s trailing twelve month EV/EBITDA is 28.69x as of 2026-06-30.